Old Web
English
Sign In
Acemap
>
authorDetail
>
Cheri Lynn Blum
Cheri Lynn Blum
Onyx Pharmaceuticals
Chemistry
Enzyme
Kinase
Enzyme inhibitor
Biochemistry
4
Papers
133
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approach.
2001
Bioorganic & Medicinal Chemistry Letters
Roger A. Smith
James Barbosa
Cheri Lynn Blum
Mark Bobko
Yolanda V Caringal
Robert Dally
Jeffrey S. Johnson
Michael E. Katz
Nancy Kennure
Jill Kingery-Wood
Wendy Lee
Timothy B. Lowinger
John Lyons
Vivienne Marsh
Daniel H Rogers
Stephen Swartz
Tracy Walling
Hanno Wild
Show All
Source
Cite
Save
Citations (78)
Inhibiteurs puriques des kinases 2 et ikb-.alpha. dependantes des cyclines
2000
Jeffery A. Zablocki
Robert T. Lum
Steven R. Schow
Prabha Ibrahim
Michael M. Wick
Richard Mackman
Cheri Lynn Blum
Show All
Source
Cite
Save
Citations (0)
Purininhibitorer of cyclin-dependent kinase 2 and LKB-alpha
1997
Robert T. Lum
Michael M. Wick
Steven R. Schow
Cheri Lynn Blum
Richard Mackman
Show All
Source
Cite
Save
Citations (0)
Synthesis and activity of 2,6,9-trisubstituted purines
1997
Bioorganic & Medicinal Chemistry Letters
Steven R. Schow
Richard Mackman
Cheri Lynn Blum
Eric E. Brooks
Amy G. Horsma
Alison Joly
S.S. Kerwar
Gavin Lee
Dov Shiffman
Marek G. Nelson
Xingbo Wang
M. Michael Wick
Xiaoming Zhang
Robert T. Lum
Show All
Source
Cite
Save
Citations (55)
1